Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 42,738 shares at $19.99 ($854K) on 2023-09-22, disclosed to the SEC on 2023-09-26.
Scheduled sale ($854k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.99 | 21,369 | $427K | 50.0% |
| 2 | $19.99 | 21,369 | $427K | 50.0% |
| Total | $19.99 avg | 42,738 | $854K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |